POSSIBILITIES OF PHARMACOLOGICAL CORRECTION OF HYPERLIPIDEMIA IN CONDITIONS OF INFLAMMATION
Journal: International Scientific Journal "Internauka" (Vol.1, No. 38)Publication Date: 2017-11-30
Authors : Makarov Alexander; Nikulin Alexander;
Page : 22-23
Keywords : lipid-lowering therapy; rosuvastatin; correction; IHD;
Abstract
As an etiological factor contributing to the activation of chronic inflammation in an atherosclerotic plaque involving the cytokine system, any acute infectious pathology occurring with an active inflammatory process can be. The article shows the features of lipid-lowering effect in patients with ischemic heart disease in combination with acute respiratory viral infection.
Other Latest Articles
- THE EVOLUTION OF PROCESS-ORIENTED PERSONNEL MANAGEMENT
- RECONSTRUCTION AND DEVELOPMENT WAY OF SETTLEMENTS IN ABSHERON ECONOMIC REGION
- THE DESIGN TRADE-EXHIBITION CENTER IN YOSHKAR-OLA
- Exploring the job demands and support resources of Intensive Care Unit nurses in Cyprus’ public hospitals
- Investigation of the attitudes of medical/nursing staff and patients towards nurse prescribing
Last modified: 2018-03-15 01:27:24